antibiotic resistant bacteria
The marriage of two innovative technologies—one developed by Northeastern’s Slava Epstein—could accelerate both the discovery of new antibiotics that kill pathogens without encountering resistance and the diagnosis of specific pathogens causing disease, enabling fast, targeted treatments.
Hospital-related staph infections are rampant, with hundreds of thousands being reported in the U.S. each year. Northeastern researcher Kim Lewis and his colleagues are at the forefront of developing new drugs to stop the trend.
The Centers for Disease Control and Prevention recently released a new report on the impact of antibiotic resistant bacteria on national health. We asked assistant professor Betsy Hirsch to explain its significance and what it means for the public.